Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
17.16 USD | +4.16% | +11.00% | +15.61% |
May. 02 | NovoCure Shares Steady After Reporting Narrower Q1 Loss, Higher Revenue | MT |
May. 02 | BioPharma Credit Enters $400 Million Loan Agreement with Novocure Luxembourg | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.61% | 1.77B | |
+73.54% | 12.41B | |
-17.34% | 8.23B | |
+3.12% | 6.46B | |
+15.76% | 5.5B | |
-5.31% | 5.33B | |
+40.80% | 5.1B | |
-18.32% | 4.05B | |
-28.31% | 2.54B | |
+7.56% | 1.99B |
- Stock Market
- Equities
- NVCR Stock
- News NovoCure Limited
- Wells Fargo Upgrades NovoCure to Overweight From Equalweight, Adjusts Price Target to $104 From $70